Precision Biosensor Inc. Q3 revenue KRW 7.0 billion, operating profit KRW 0.4 billion, turning profitable
AI summary · Not investment advice
Precision Bio sold KRW 7.0 billion in Q3 and earned KRW 0.4 billion from its main business, turning profitable from a loss a year earlier.
Operating profit · 3 months
KRW 412.0 million
Key facts
- Revenue (3 months)
- KRW 7.0 billion
- Net income (3 months)
- KRW -519.4 million
- Period
- Q3 (cumulative 2026.01.01 ~ 2026.09.30)
- Revenue (prior-year 3 months)
- KRW 5.1 billion
- Revenue (year to date)
- KRW 20.3 billion
- Operating profit (prior-year 3 months)
- KRW -1.0 billion
- Operating profit (year to date)
- KRW -779.7 million
- Net income (prior-year 3 months)
- KRW -1.5 billion
- Net income (year to date)
- KRW -1.6 billion
Commentary
AI commentary · Not investment advice
What happened
Precision Bio filed its quarterly report with consolidated results for the third quarter of 2026. Sales for the latest 3 months were KRW 7.02 billion. That is 37.2% higher than the same 3 months a year earlier, which were KRW 5.12 billion.
In the company's terms
Operating profit (money earned from the core business) was KRW 412 million for the latest 3 months. A year earlier, the same period showed an operating loss of KRW 1.03 billion. So it turned to a profit.
What changes for shareholders
Net income (the final profit after taxes and other items) was a loss of KRW 519 million for the latest 3 months. A year earlier, the loss was KRW 1.52 billion.
For the year to date (January 1 to September 30), sales were KRW 20.27 billion. Operating loss was KRW 780 million. Net loss was KRW 1.55 billion.
Comments
No comments yet
Comments from shareholders will appear here.
Ad
Verify your holdings and catch the next disclosure
Verify the stocks you hold and get new disclosures as app alerts.

App design sample
Get the next disclosure as an app alert
Get app alerts for new disclosures and stake changes on your watchlist
P